Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jul 3:370:m2655.
doi: 10.1136/bmj.m2655.

Antibody testing for coronavirus disease 2019: not ready for prime time

Affiliations
Editorial

Antibody testing for coronavirus disease 2019: not ready for prime time

Yen T Duong et al. BMJ. .

Abstract

The tests need work, and fundamental questions remain about immunity

PubMed Disclaimer

Conflict of interest statement

Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none. The BMJ policy on financial interests is here: https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf.

Comment on

References

    1. Zhu N, Zhang D, Wang W, et al. China Novel Coronavirus Investigating and Research Team A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727-33. 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
    1. Lisboa Bastos M, Tavaziva G, Abidi SK, et al. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ 2020;370:m2516 10.1136/bmj.m2516 - DOI - PMC - PubMed
    1. Premkumar L, Segovia-Chumbez B, Jadi R, et al. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Sci Immunol 2020;5:eabc8413. 10.1126/sciimmunol.abc8413. - DOI - PMC - PubMed
    1. Deeks JJ, Dinnes J, Takwoingi Y, et al. Cochrane COVID-19 Diagnostic Test Accuracy Group Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev 2020;6:CD013652. 10.1002/14651858.CD013652. - DOI - PMC - PubMed
    1. Bond K, Nicholson S, Lim S, et al. Evaluation of serological tests for SARS-CoV-2: Implications for serology testing in a low-prevalence setting. medRxiv 20118273 [Preprint]. 2020. 10.1101/2020.05.31.20118273 - DOI - PMC - PubMed